Our Goal
Diabetes prevalence in the United States
To improve the lives of people with diabetes through support for diabetes research funding and improved clinical care.
Why We Care
Endocrinologists are often on the frontlines of the all-consuming, complex diabetes public health crisis. The Endocrine Society works to make a positive difference in the lives of patients with diabetes, and advocates for access to affordable care and diabetes supplies, and better funding for research focused on diabetes and its comorbidities.
Position Papers
- Increasing Insulin Affordability | November 2018
- Affordable Care Act Implementation: Challenges and Opportunities to Impact Patients With Diabetes | January 2016
- Pediatric Obesity | November 2011
- Access to Affordable and Adequate Diabetes Supplies | October 2007
Policy Communications
- Letter of Support for CGM Coverage | October 9, 2019
- Diabetes Advocacy Alliance Letter to the National Clinical Care Commission | October 8, 2019
- Coalition Letter on Special Diabetes Reauthorization | September 17, 2019
- Diabetes Policy Collaborative Letter to UnitedHealth Group | August 26, 2019
- Letter and Resources to Energy & Commerce Committee Members on Insulin Affordability | June 25, 2019
- Senate Comments on the Lower Health Care Costs Act of 2019 | June 4, 2019
- Endocrine Society Testimony on the Special Diabetes Program (SDP) | May 31, 2019
- Endocrine Society FDA Testimony on Biosimilars | May 10, 2019
- Coalition Letter to CVS on Diabetes Test Strip Policy | May 3, 2019
- Endocrine Society Statement on Insulin Pricing to E&C Subcommittee on Oversight & Investigations | April 10, 2019
- ES Response to HHS Rebate Proposal to Lower Drug Costs | April 8, 2019
- Testimony to House Energy & Commerce Oversight and Investigations Subcommittee on Rising Insulin Costs by Endocrine Society Member Alvin C. Powers | April 2, 2019
- The Endocrine Society Responds to a Telehealth Request for Information | March 28, 2019
- DAA Coalition Comments in Response to USPSTF Draft Research Plan for Gestational Diabetes Mellitus: Screening | March 27, 2019
- DAA Coalition Comments on Telehealth | March 27, 2019
- Diabetes Advocacy Alliance Letter of Support for the Expanding Access to Diabetes Self-Management Training (DSMT) Act | March 13, 2019
- Diabetes Advocacy Alliance Letter in Support of Funding for the National Diabetes Prevention Program in FY2020 | March 12, 2019
- More...
Friends of the Court Briefs
- American Diabetes Association v United States Department of the Army | June 28, 2018
- Richardson v Chicago Transit Authority |August 27, 2018
Diabetes Disaster Response Coalition (DDRC)
In response to the active and devastating 2017 hurricane season, the Endocrine Society, along with seven other organizations formed a coalition to coordinate and deliver diabetes supplies to individuals left without access to water and electricity. DDRC members are committed to delivering life-saving medical care and supplies to areas affected by disasters.
For more information on DDRC activities and alerts, please visit our page.
Hypoglycemia Prevention Initiative
Since 2014, the Endocrine Society has made hypoglycemia a strategic priority, conducting a series of roundtables with key stakeholders from the federal government, provider community, patient advocates, and payers to determine a comprehensive approach to this problem. The Endocrine Society’s Hypoglycemia Prevention Initiative is committed to:
- Decreasing the population of patients with T2D on insulin and/or SUs who are high risk for hypoglycemia as an ADE, and;
- Decreasing the frequency and severity of hypoglycemia as an ADE among patients with T2D on insulin and/or SUs who are identified as high risk.
To learn more about HPI’s progress and activities, please visit our page at endocrine.org/hypoprevent
Progress
Autoimmune Diabetes Outcomes and Anti-Cancer Agents
In this Endocrine News Podcast Anupam Kotwal talks about his research on the potential for autoimmune diabetes outcomes from novel anti-cancer agents.
- Endocrine Society Members Partner with Patients and Caregivers to Advocate on Diabetes | October 2018
The Endocrine Society partnered with the Diabetes Patient Advocacy Coalition to advocate for increased access to diabetes self-management training services and to educate Members of Congress about ways to address rising insulin costs. - National Diabetes Coalition Urges People with Diabetes to Prepare for Hurricane Florence | September 2018
The Endocrine Society, along with other members of the Diabetes Disaster Response Coalition urged residents with diabetes who are living in North Carolina, South Carolina, Georgia, and Virginia to prepare for the oncoming Hurricane Florence. - ASAE Honors Endocrine Society, Partners with 2018 Summit Power of A Award | June 2018
The Diabetes Emergency Relief Coalition, composed of the Endocrine Society and seven other leading diabetes care and research organizations, will receive the American Society of Association Executives (ASAE) 2018 Summit Power of A Award for helping to provide critical diabetes supplies to regions impacted by Hurricanes Harvey, Irma and Maria. - AMA Urges Federal Action to Respond to Insulin Price Hikes | June 2018
The American Medical Association responded to a resolution proposed by the Endocrine Society related to insulin price hikes. - Endocrine Society, ADA, AACE, AADE Strongly Disagree with ACP’s Recent Diabetes Statement | March 2018
Together, the Endocrine Society, the American Diabetes Association (ADA), the American Association for Clinical Endocrinologists (AACE), and the American Association of Diabetes Educators (AADE) strongly disagree with the American College of Physicians’ (ACP’s) proposed new guidance that suggests higher blood glucose targets for people with type 2 diabetes.
- Endocrine Society Applauds Special Diabetes Program Renewal | February 2018
The Endocrine Society praised Congress’ decision to include the Special Diabetes Program and increased funding for the National Institutes of Health (NIH) in a Continuing Resolution (CR) to fund the federal government. - Endocrine Society Lauds Expanded Access to Diabetes Tech for Medicare Patients | January 2018
The Endocrine Society applauded the move by the Centers for Medicare and Medicaid Services (CMS) to extend older Americans’ access to insulin delivery devices used to treat diabetes as part of Medicare Part D. - More...
Clinical Practice Guidelines
- Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults | 2016
- Diabetes and Pregnancy | 2013
- Management of Hyperglycemia in Hospitalized Patients in Non-critical Care Setting | 2012
- Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline | 2011
- Evaluation and Management of Adult Hypoglycemic Disorders | 2009
Scientific Statement
Resources
- Testimony to Senate Special Committee on Aging regarding Insulin Access and Affordability | May 18, 2018
- An estimated 26 million Americans have diabetes, a disease in which there is too much sugar in the bloodstream. About 7 million of them, however, have not yet been diagnosed with the disease. Talk with your doctor if you have symptoms of diabetes and for more information please visit Hormone.org
- Diabetes Facts and Figures
